More Company News

Nexstim

FY21 financial results
28 Feb 2022Read More

Nexstim

Technology licenced to Magnus Medical
14 Feb 2022Read More

Nexstim

Patient registry reaches over 300 completed treatment sessions
03 Feb 2022Read More

Nexstim

Results of pilot study in chronic pain Helsinki University Hospital
15 Dec 2021Read More

Nexstim

Strategic investment into management services organisation of a California-based depression clinic
22 Nov 2021Read More

Nexstim

Cooperation with private Finnish clinic
05 Nov 2021Read More

Nexstim

Q321 business and clinical update
20 Oct 2021Read More

Nexstim

System orders from existing hospital customers in Finland
15 Sep 2021Read More

Nexstim

Continuation of severe depression pilot study at Kuopio University Hospital
23 Aug 2021Read More

Nexstim

MDD Patient Registry reaches 208 completed treatment sessions
20 Aug 2021Read More

1 2 3 4 … 13
Return to Nexstim
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).